Skip to content
Aerpio Pharmaceuticals
  • Contact Us
  • Careers
  • About Aerpio
    • Management
    • Board of Directors
    • Advisory Board
  • Tie2 Pathway
    • The Basics
    • VE-PTP and Ang-2
  • Pipeline
    • AKB-9778
    • ARP-1536
    • AKB-4924
    • Clinical Trials
  • Therapeutic Areas
    • Diabetic Retinopathy
    • Glaucoma
    • Wet AMD / DME
    • IBD
  • Investors
  • Publications
Aerpio Pharmaceuticals
  • Advancing first-in-class treatments targeting
    the Tie2 pathway for ocular diseases
  • Aiming to stabilize vasculature in the most
    common retinopathies
  • With an innovative approach that may represent
    the most efficient way to restore Tie2 activation

Home

About Aerpio ABOUT TIE2 – VE PTP

© Aerpio

  • Site Map
  • Terms of Use
  • Privacy Policy
Website by Axxiem